Submit Deal

TRAWSFYNYDD THERAPEUTICS

Summary

Trawsfynydd Therapeutics a privately-held biotechnology company developing next-generation antivirals for influenza, COVID and other infectious diseases.

Deals Overview

Total Deals1

Valued Deals0

Total Value-

Avg. Deal Size-

Market Context

Senior Management

Nikolay Savchuk
CEO

Sort

02 Apr 2024|United States|Biotechnology

Target: TRAWSFYNYDD THERAPEUTICS

Bidder: ONCONOVA THERAPEUTICS

7 Service Providers

3 Target | 4 Bidder

5 Dealmakers

2 Target | 3 Bidder

n/a

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy